Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6N4O3S |
Molecular Weight | 214.202 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CN=C(S1)N2CCNC2=O
InChI
InChIKey=RDXLYGJSWZYTFJ-UHFFFAOYSA-N
InChI=1S/C6H6N4O3S/c11-5-7-1-2-9(5)6-8-3-4(14-6)10(12)13/h3H,1-2H2,(H,7,11)
Molecular Formula | C6H6N4O3S |
Molecular Weight | 214.202 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Niridazole is used (but not officially recommended) for the treatment of schistosomiasis, dracunculiasis and tungiasis. The mode of action of niridazole is not fully understood. The major action of niridazole seems to be on the glycogen metabolism of the helminths. The drug also case structural damage to the reproductive system of female schistosomes. Another possible mechanism of action of niridazole involves the inhibition of DNA synthesis in schistosomes. It is metabolized in the liver. The most serious side effects were those connected with the nervous area (convulsion, hallucination, etc.).
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial. | 1974 Jul |
|
Anthelmintics: a review. | 2001 Oct-Dec |
|
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. | 2005 Sep 22 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6703680
Niridazole was dissolved in dimethyl sulfoxide to obtain a solution at 1,000 ug/ml. It was further diluted in distilled water and mixed with Mueller-Hinton agar to obtain graded concentrations from 0.001 to 8 ug/ml. The minimal inhibitory concentrations of niridazole for C. fetus subsp. Jejeuni was substantially higher than that of metronidazole. The break point of niridazole may tentatively be fixed between 4 and 8 ug/ml of active drug.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:03:42 GMT 2023
by
admin
on
Fri Dec 15 15:03:42 GMT 2023
|
Record UNII |
N116U8Y5QQ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
||
|
WHO-ATC |
P02BX02
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
||
|
IARC | Niridazole |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2234
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
C90757
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
NIRIDAZOLE
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | Description: A yellow, crystalline powder; odourless or almost odourless. Solubility: Practically insoluble in water and ether R; soluble in dimethylformamide R and pyridine R; slightly soluble in ethanol(~750 g/l) TS and acetone R. Category: Antischistosomal drug.Storage: Niridazole should be kept in a tightly closed container. Definition: Niridazole contains not less than 97.0% and not more than 103.0% of C6H6N4O3S, calculated with reference to thedried substance. | ||
|
DB13661
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
N116U8Y5QQ
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
100000083888
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
DTXSID6045244
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
Niridazole
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL152632
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
m7919
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | Merck Index | ||
|
200-512-6
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
61-57-4
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
D009560
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
7480
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
6093
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
1941
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
SUB09304MIG
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY | |||
|
136947
Created by
admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |